Julian Raynov

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial

Richard Greil, Petra Obrtlíková, Lukáš Smolej et al. · The Lancet Haematology · 2016 · 46 citations

Medicine, Hematology, Immunology +11

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial

Kathleen M. Mullane, Vicki A. Morrison, Luis H. Camacho et al. · The Lancet Infectious Diseases · 2019 · 36 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Serum level changes of matrix metalloproteinases 2 and 9, vascular endothelial growth factor and epidermal growth factor receptor during platinum-based chemotherapy in advanced non-small cell lung cancer patients.

Zhasmina Mihaylova, Vienna Ludovini, V. Gregorg et al. · PubMed · 2007 · 21 citations

Medicine, Oncology, Pharmacology +15

A randomized, placebo-controlled, double blind, multicenter phase II adjuvant trial of the efficacy, immunogenicity, and safety of GI-4000 plus gem versus gem alone in patients with resected pancreas cancer with activating RAS mutations/survival and immunology analysis of the R1 subgroup.

Peter Muscarella, Lalan S. Wilfong, Sharona Ross et al. · Journal of Clinical Oncology · 2012 · 18 citations

Medicine, Immunology, Oncology +16

Can genome array screening replace FISH as a front‐line test in multiple myeloma?

Temenushka Boneva, Diana Brazma, Katya Gancheva et al. · Genes Chromosomes and Cancer · 2014 · 14 citations

Medicine, Hematology, Molecular Genetics +17